DORAVIRINE, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE

94 reported adverse events

Drug classes: Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]

These side effects are most commonly reported by patients taking DORAVIRINE, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE:

#	Side effect	Count
0	WEIGHT INCREASED	14
1	NAUSEA	13
2	PAIN	12
3	ANXIETY	10
4	EMOTIONAL DISTRESS	9
5	ANHEDONIA	7
6	DEPRESSION	7
7	DIARRHOEA	7
8	DYSPNOEA	7
9	HEADACHE	7

See all common reactions for DORAVIRINE, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE

DORAVIRINE, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE is most commonly taken among patients reporting these side effects:

#	Side effect	Count	Frequency
0	WAIST CIRCUMFERENCE	1	0.3333
1	BLOOD HIV RNA BELOW ASSAY LIMIT	2	0.1333
2	VIRAL LOAD ABNORMAL	1	0.0139
3	ALCOHOL USE DISORDER	1	0.0120
4	ACETABULUM FRACTURE	2	0.0066
5	HEPATITIS B CORE ANTIBODY POSITIVE	1	0.0038
6	ENTERAL NUTRITION	1	0.0036
7	STRESS AT WORK	2	0.0025
8	MYCOBACTERIUM ABSCESSUS INFECTION	1	0.0024
9	CRITICAL ILLNESS	1	0.0023

See all enriched reactions for DORAVIRINE, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE